Here we reported the first case of a Chinese HPGD-mutated PHO patient with soft tissue giant tumors at bilateral lower legs, as well as evaluated the efficacy of selective COX-2 inhibition (etoricoxib) treatment in this patient. The gene discussed is HPGD; the disease is primary hypertrophic osteoarthropathy.